Table of contents

  • Brand Names
  • Chemistry
  • Pharmacologic Category
  • Mechanism of Action
  • Therapeutic Use
  • Unlabeled Use
  • Pregnancy and Lactation Implications
  • Contraindications
  • Warnings and Precautions
  • Adverse Reactions
  • Caution and personalized dose adjustment in patients with the following genotypes
  • Other genes that may be involved
  • Inhibits
  • Drug Interactions
  • Dosage
  • Pharmacokinetics and Pharmacodynamics
  • Special Considerations

Brand Names


Greece: Dacogen.

North America

USA: Dacogen.

Latin America

Argentina: Dacogen.

Drug combinations


Decitabine: C~8~H~12~N~4~O~4~. Mw: 228.21. (1) 1,3,5-Triazin-2(1H)-one, 4-amino-1-(2-deoxy-β-D-erythro-pentofuranosyl)-; (2) 4-Amino-1-(2-deoxy-β-D-erythro-pentofuranosyl)-s-triazin-2(1H)-one; (3) 5-Aza-2′-deoxycytidine. CAS-2353-33-5 (1989).

Pharmacologic Category

Antineoplastic Agents; Antimetabolites; DNA Methyltransferase Inhibitor. (ATC-Code: L01BC08).

Mechanism of action

Synthetic nucleoside analog of 2′-Deoxycytidine. After phosphorylation, decitabine is incorporated into DNA and inhibits DNA methyltransferase causing hypomethylation and subsequent cell death.

Therapeutic use

Treatment of myelodysplastic syndrome. Designated an orphan drug by the FDA for use in this condition.

Pregnancy and lactiation implications

Teratogenic effects in animal studies. Males should avoid fathering a child during therapy and for 2 months after. Pregnancy should be avoided during therapy. Not recommended during lactation.

Unlabeled use

Treatment of acute myelogenous leukemia, chronic myelogenous leukemia, or sickle cell anemia.


Hypersensitivity to decitabine or any component of the formulation.

Warnings and precautions

Bone marrow suppression (anemia, severe neutropenia, and severe thrombocytopenia) is the most common cause of decitabine dosage delay, reduction, or discontinuance. Caution in hepatic or renal impairment (use not studied). Infectious complications reported in clinical trials.



Legal Notice
Privacy Policy
Cookie Policy


Phone: +34-981-780505
Location: Sta Marta de, C. P. Babío, S/N, 15165 Bergondo, A Coruña

Copyright © 2023 WAGEM

Add to cart